SPY317.59+3.21 1.02%
DIA260.82+3.58 1.39%
IXIC10,617.44+69.69 0.66%

X4 Pharmaceuticals Receives Breakthrough Therapy Designation From FDA For Mavorixafor In The Treatment Of WHIM Syndrome

Benzinga · -